Publisher Correction: Combined inhibition of protein kinase B and enhancer of zeste homolog 2: a novel strategy to induce triple-negative breast cancer cell death
Saved in:
| Main Authors: | Xinxiao Zhu, Yongqiang Wang, Long Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-08-01
|
| Series: | Molecular Biomedicine |
| Online Access: | https://doi.org/10.1186/s43556-025-00302-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined inhibition of protein kinase B and enhancer of zeste homolog 2: a novel strategy to induce triple-negative breast cancer cell death
by: Xinxiao Zhu, et al.
Published: (2025-07-01) -
Enhancer of zeste homolog 1/2 dual inhibitor valemetostat outperforms enhancer of zeste homolog 2-selective inhibitors in reactivating latent HIV-1 reservoirs ex vivo
by: Ayako Sedohara, et al.
Published: (2025-04-01) -
Assessment of the Therapeutic Potential of Enhancer of Zeste Homolog 2 Inhibition in a Murine Model of Bronchiolitis Obliterans Syndrome
by: Kyoto Matsudo, et al.
Published: (2024-10-01) -
Knockdown of A-kinase anchor protein 4 inhibits proliferation of triple-negative breast cancer cells and
by: Nirmala Jagadish, et al.
Published: (2020-04-01) -
A systems approach identifies Enhancer of Zeste Homolog 2 (EZH2) as a protective factor in epilepsy.
by: Nadia Khan, et al.
Published: (2019-01-01)